Back to Companies
Coherus Oncology, Inc.
CHRSNasdaqCIK: 0001512762
Recent Form 4 activity at Coherus Oncology, Inc. (CHRS) spans 13 filings across 9 insiders (no open-market buying or selling). Lanfear Dennis M (President & CEO, Director) is the most active by dollar volume, and the single largest transaction was $44.2M by Lanfear Dennis M. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$49.3M
Purchases
$0
Sales
$0
Unique Insiders
9
Recent Insider Trades
13 loaded
| Jun 9 | CHRS Coherus Oncology, Inc. | Karachun Rita A | Insider | Grant | $87.0K |
| Jun 9 | CHRS Coherus Oncology, Inc. | Wahlstrom Mats | Insider | Grant | $87.0K |
| Jun 9 | CHRS Coherus Oncology, Inc. | O'Donnell-Tormey Jill | Insider | Grant | $87.0K |
| Jun 9 | CHRS Coherus Oncology, Inc. | Satvat Ali J. | Insider | Grant | $87.0K |
| Jun 9 | CHRS Coherus Oncology, Inc. | Ryan Michael Lee | Insider | Grant | $87.0K |
| Jun 9 | CHRS Coherus Oncology, Inc. | Newcomer Lee Nisley | Insider | Grant | $87.0K |
| Jun 9 | CHRS Coherus Oncology, Inc. | Newton Charles W. | Insider | Grant | $87.0K |
| Jun 2 | CHRS Coherus Oncology, Inc. | McMichael Bryan J | Chief Financial Officer | Award | $2.6M |
| Jun 2 | CHRS Coherus Oncology, Inc. | Lanfear Dennis M | President & CEO, Director | Award | $44.2M |
| Jan 26 | CHRS Coherus Oncology, Inc. | Lanfear Dennis M | Insider | Grant | $1.5M |
| Jan 26 | CHRS Coherus Oncology, Inc. | McMichael Bryan J | Insider | Grant | $357.8K |
| Jan 22 | CHRS Coherus Oncology, Inc. | Lanfear Dennis M | Insider | Tax withheld | $18.4K |
| Jan 22 | CHRS Coherus Oncology, Inc. | McMichael Bryan J | Insider | Tax withheld | $2.7K |
13 filings